Norges Bank Legend Biotech Corp Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$25.8 - $32.39 $613,962 - $770,784	-23,797 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$27.5 - $39.61 $654,417 - $942,599	23,797 New	23,797 $735,000
Q3 2020 Nov 10, 2020	SELL	$27.5 - $39.61 $654,417 - $942,599	-23,797 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$36.1 - $42.56 $859,071 - $1.01 Million	23,797 New	23,797 $1.01 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.